UBM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ulisse Biomed Spa

Watchlist Manager

Watchlist

Price: 0.78 EUR -2.26% Market Closed

Market Cap: €19.9m

	Ulisse Biomed Spa MIL:UBM	IT
	Sammaan Capital Ltd NSE:SAMMAANCAP	IN
E	ESR Cayman Ltd HKEX:1821	HK
	Antero Midstream Corp NYSE:AM	US
	National Energy Services Reunited Corp NASDAQ:NESR	US
B	Beijing Tianma Intelligent Control Technology Co Ltd SSE:688570	CN
	Teva Pharmaceutical Industries Ltd TASE:TEVA	IL
	Insmed Inc NASDAQ:INSM	US
H	HLB Inc KOSDAQ:028300	KR
B	Baltic Classifieds Group PLC LSE:BCG	UK
	Martin Marietta Materials Inc NYSE:MLM	US
C	Canal+ SA LSE:CAN	FR

Profitability Summary

Ulisse Biomed Spa's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-87%

Negative 3Y Average Gross Margin

-795%

Gross Margin is Increasing

-647% > -87%

Negative Operating Margin

-571%

Negative 3Y Average Operating Margin

-2 416%

Operating Margin is Increasing

-944% > -571%

Negative Net Margin

-573%

Negative 3Y Average Net Margin

-2 418%

Net Margin is Increasing

-945% > -573%

Negative Free Cash Flow Margin

-296%

Negative 3Y Average Free Cash Flow Margin

-893%

Free Cash Flow Margin is Increasing

-866% > -296%

Negative ROE

-23%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-37%

ROIC is Increasing

-49% > -22%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.